Delivery Order SPE2DB24D1201-SPE2DB25FJDGD

Award Date 6/30/25
Potential Completion Date 7/1/25
Potential Value $12K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $17,086.27 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order is for the supply of COSENTYX UNOREADY 300 mg pen, a specialty pharmaceutical product. The award is not set aside and has an ultimate completion date of June 4, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a $10,456.36 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of COSENTYX UNOREADY 300 MG PEN 2ML, a pharmaceutical product, with a period of performance through July 2, 2025. The award is not set-aside and represents an individual delivery order under Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC)...
This is a $11,991.32 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of COSENTYX UNOREADY 300 MG PEN 2ML, a prescription medication. This delivery order is associated with a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides comprehensive global...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,984.06 firm-fixed-price delivery order is for the supply of COSENTYX UNOREADY 300 MG PEN 2ML, a specialty pharmaceutical product. The contract has an ultimate completion date of January 21, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a $7,986.23 delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of COSENTYX UNOREADY 300 MG PEN 2ML, with a completion date of June 18, 2025. The contract is a firm fixed price arrangement and is not set aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,508.20, is for the delivery of COSENTYX UNOREADY 300 MG PEN 2ML medical supplies. The contract has an ultimate completion date of May 20, 2025 and is not a set-aside award. Amerisourcebergen Drug Corp is the prime contractor for this delivery order, which is a part of the company's...
This is a $25,293.55 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of COSENTYX UNOREADY 300 MG PEN 2ML, a medical product, with a period of performance through June 25, 2025. The order is not set aside and represents an open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $5,997.42 firm fixed-price delivery order is for the supply of COSENTYX UNOREADY 300 MG PEN 2ML, a specialty medication. The contract has an ultimate completion date of February 14, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,547.07 contract is for the supply of 4567953352 COSENTYX UNOREADY 300 MG PEN 2ML, a prescription medication. The contract has an ultimate completion date of April 18, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no indication of any major subcontractors. This award is not...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $31,909.71, is for the supply of COSENTYX UNOREADY 300 MG PEN 2ML, a pharmaceutical product. The contract is a firm fixed-price, non-set-aside award with a performance period through June 17, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
  • SPE2DB24D1201
    Indefinite Delivery Contract
  • SPE2DB24D1201-SPE2DB25FJDGD
    Delivery Order

This is a $12,167.93 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of COSENTYX UNOREADY 300 MG PEN 2ML, a pharmaceutical product, with a performance period through July 1, 2025.

Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX, which provides a comprehensive global pharmaceutical support vehicle with a performance period through December 2026. This prime contract allows for multiple delivery orders across different therapeutic categories, positioning Amerisourcebergen as a critical vendor in supporting federal medical procurement needs, particularly for military and veteran healthcare systems.

The contract award is not designated as a set-aside. Amerisourcebergen Drug Corp is a for-profit organization and the parent company of this contract award.

Generated 10/5/25, 1:08 AM